Circadian Rhythm Sleep Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
310 Pages
January 2024
Region: Global
Fairfield Market Research
ID: 5934345

The global Circadian Rhythm Sleep Treatment Market is poised for significant growth from 2024 to 2031. Starting at US$740 million in 2024, the market is projected to expand to US$990 million by 2031.

Growth Factors:

The global Circadian Rhythm Sleep Treatment Market is witnessing significant growth due to the rising prevalence of sleep disorders, including Delayed Sleep Phase Syndrome, Advanced Sleep Phase Syndrome, Non–24-h sleep-wake syndrome. This increased need for proper sleep treatment is driving market expansion. Additionally, the market is propelled by product advancements in therapy devices and the adoption of drugs for circadian rhythm sleep treatment.

Furthermore, a disrupted sleep pattern poses an increased risk of fatal accidents, with estimates suggesting a potential doubling of global deaths in car accidents and a notable portion attributed to exhaustion or drowsiness. Similarly, workplace accidents are projected to rise due to disrupted sleep. This elevated risk of fatal accidents contributes to an increased demand for circadian rhythm sleep treatment, further propelling market growth.

Restraints

Limited awareness about the critical issues related to circadian rhythm sleep disorders in underdeveloped nations could hinder the expansion of the circadian rhythm sleep treatment market. Additionally, negligence towards potential drug side effects and insufficient attention to sleep problems may impede the market's growth.

Competitive Analysis

The Circadian Rhythm Sleep Treatment industry is characterized by intense competition and significant consolidation, primarily driven by major players. Mergers and acquisitions are prominent strategies as the industry experiences growth. Key market players are strategically opting for these initiatives to expand their product portfolios and increase market share.

One notable player, Natus Medical Incorporated in the USA, has introduced the Embla N7000 system designed for overnight PSG (Polysomnography) between 10 p.m. and 6 a.m. The system is supervised by experienced sleep physicians following the guidelines outlined in the AASM manual 2.5.

In addition to inorganic expansion through mergers and acquisitions, companies are also exploring organic growth strategies. Continuous innovation remains vital for the circadian rhythm sleep treatment market, and this trend is expected to persist throughout the forecast period (2024-2031).

Key players in the Circadian Rhythm Sleep Treatment Market including:

Natus Medical Incorporated
Compumedics Ltd. -
Teva Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company
Koninklijke Philips N.V
Mylan N.V
Fitbit, Inc
Garmin Ltd
Lucimed S.A.
RedMed Inc.
Compass Health Brands (Carex Health)
Beurer GmbH
Samarit Medical AG
Lanaform N.V.

Circadian Rhythm Sleep Treatment Market Categorization

Circadian Rhythm Sleep Treatment Market by Disorder

Delayed Sleep Phase Syndrome
Advanced Sleep Phase Syndrome
Non–24-h sleep-wake syndrome
Irregular Sleep-Wake Disorder
Shift Work Disorder
Jet Lag

Circadian Rhythm Sleep Treatment Market by Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Circadian Rhythm Sleep Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Circadian Rhythm Sleep Treatment Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis, by Treatment Type, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Circadian Rhythm Sleep Treatment Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

5.1. Global Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Device
5.1.1.1.1. Therapeutic Devices
5.1.1.1.1.1. Light Box
5.1.1.1.1.2. Desk Lamps
5.1.1.1.1.3. Light Visor
5.1.1.1.1.4. Dawn Simulator
5.1.1.1.2. Diagnostic Devices
5.1.1.1.2.1. Actigraphy Sensors
5.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
5.1.1.1.2.1.2. Wearable Actigraphy Devices
5.1.1.1.2.2. Polysomnography Devices
5.1.1.1.2.2.1. Fixed Polysomnography Devices
5.1.1.1.2.2.2. Portable Polysomnography Devices
5.1.1.2. Drugs
5.1.1.2.1. Benzodiazepines
5.1.1.2.2. Nonbenzodiazepine hypnotics
5.1.1.2.3. Orexin receptor antagonists
5.1.1.2.4. Melatonin receptor agonist
5.1.1.3. Chronotherapy
5.2. Global Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
5.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
5.2.1.3. Non-24-h Sleep-Wake Syndrome
5.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
5.2.1.5. Shift Work Disorder
5.2.1.6. Jet Lag
5.3. Global Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Institutional Sales
5.3.1.1.1. Home Care Settings
5.3.1.1.2. Wellness Centers & Spa
5.3.1.1.3. Sleep Testing Centers
5.3.1.1.4. Specialty Clinics
5.3.1.1.5. Hospitals
5.3.1.2. Retail Sales
5.3.1.2.1. Retail Pharmacies
5.3.1.2.2. Drug Stores
5.3.1.2.3. Online Sales
5.4. Global Circadian Rhythm Sleep Treatment Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa

6. North America Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

6.1. North America Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Device
6.1.1.1.1. Therapeutic Devices
6.1.1.1.1.1. Light Box
6.1.1.1.1.2. Desk Lamps
6.1.1.1.1.3. Light Visor
6.1.1.1.1.4. Dawn Simulator
6.1.1.1.2. Diagnostic Devices
6.1.1.1.2.1. Actigraphy Sensors
6.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
6.1.1.1.2.1.2. Wearable Actigraphy Devices
6.1.1.1.2.2. Polysomnography Devices
6.1.1.1.2.2.1. Fixed Polysomnography Devices
6.1.1.1.2.2.2. Portable Polysomnography Devices
6.1.1.2. Drugs
6.1.1.2.1. Benzodiazepines
6.1.1.2.2. Nonbenzodiazepine hypnotics
6.1.1.2.3. Orexin receptor antagonists
6.1.1.2.4. Melatonin receptor agonist
6.1.1.3. Chronotherapy
6.2. North America Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
6.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
6.2.1.3. Non-24-h Sleep-Wake Syndrome
6.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
6.2.1.5. Shift Work Disorder
6.2.1.6. Jet Lag
6.3. North America Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Institutional Sales
6.3.1.1.1. Home Care Settings
6.3.1.1.2. Wellness Centers & Spa
6.3.1.1.3. Sleep Testing Centers
6.3.1.1.4. Specialty Clinics
6.3.1.1.5. Hospitals
6.3.1.2. Retail Sales
6.3.1.2.1. Retail Pharmacies
6.3.1.2.2. Drug Stores
6.3.1.2.3. Online Sales
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. U.S. Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.2. U.S. Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.3. U.S. Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.4. Canada Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.5. Canada Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.6. Canada Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

7.1. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Device
7.1.1.1.1. Therapeutic Devices
7.1.1.1.1.1. Light Box
7.1.1.1.1.2. Desk Lamps
7.1.1.1.1.3. Light Visor
7.1.1.1.1.4. Dawn Simulator
7.1.1.1.2. Diagnostic Devices
7.1.1.1.2.1. Actigraphy Sensors
7.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
7.1.1.1.2.1.2. Wearable Actigraphy Devices
7.1.1.1.2.2. Polysomnography Devices
7.1.1.1.2.2.1. Fixed Polysomnography Devices
7.1.1.1.2.2.2. Portable Polysomnography Devices
7.1.1.2. Drugs
7.1.1.2.1. Benzodiazepines
7.1.1.2.2. Nonbenzodiazepine hypnotics
7.1.1.2.3. Orexin receptor antagonists
7.1.1.2.4. Melatonin receptor agonist
7.1.1.3. Chronotherapy
7.2. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
7.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
7.2.1.3. Non-24-h Sleep-Wake Syndrome
7.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
7.2.1.5. Shift Work Disorder
7.2.1.6. Jet Lag
7.3. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Institutional Sales
7.3.1.1.1. Home Care Settings
7.3.1.1.2. Wellness Centers & Spa
7.3.1.1.3. Sleep Testing Centers
7.3.1.1.4. Specialty Clinics
7.3.1.1.5. Hospitals
7.3.1.2. Retail Sales
7.3.1.2.1. Retail Pharmacies
7.3.1.2.2. Drug Stores
7.3.1.2.3. Online Sales
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Germany Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.2. Germany Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.3. Germany Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.4. U.K. Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.5. U.K. Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.6. U.K. Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.7. France Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.8. France Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.9. France Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.10. Italy Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.11. Italy Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.12. Italy Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.13. Turkey Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.14. Turkey Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.15. Turkey Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.16. Russia Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.17. Russia Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.18. Russia Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.19. Rest of Europe Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.20. Rest of Europe Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.21. Rest of Europe Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

8.1. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Device
8.1.1.1.1. Therapeutic Devices
8.1.1.1.1.1. Light Box
8.1.1.1.1.2. Desk Lamps
8.1.1.1.1.3. Light Visor
8.1.1.1.1.4. Dawn Simulator
8.1.1.1.2. Diagnostic Devices
8.1.1.1.2.1. Actigraphy Sensors
8.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
8.1.1.1.2.1.2. Wearable Actigraphy Devices
8.1.1.1.2.2. Polysomnography Devices
8.1.1.1.2.2.1. Fixed Polysomnography Devices
8.1.1.1.2.2.2. Portable Polysomnography Devices
8.1.1.2. Drugs
8.1.1.2.1. Benzodiazepines
8.1.1.2.2. Nonbenzodiazepine hypnotics
8.1.1.2.3. Orexin receptor antagonists
8.1.1.2.4. Melatonin receptor agonist
8.1.1.3. Chronotherapy
8.2. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
8.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
8.2.1.3. Non-24-h Sleep-Wake Syndrome
8.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
8.2.1.5. Shift Work Disorder
8.2.1.6. Jet Lag
8.3. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Institutional Sales
8.3.1.1.1. Home Care Settings
8.3.1.1.2. Wellness Centers & Spa
8.3.1.1.3. Sleep Testing Centers
8.3.1.1.4. Specialty Clinics
8.3.1.1.5. Hospitals
8.3.1.2. Retail Sales
8.3.1.2.1. Retail Pharmacies
8.3.1.2.2. Drug Stores
8.3.1.2.3. Online Sales
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. China Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.2. China Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.3. China Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.4. Japan Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.5. Japan Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.6. Japan Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.7. South Korea Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.8. South Korea Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.9. South Korea Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.10. India Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.11. India Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.12. India Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.13. Southeast Asia Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.14. Southeast Asia Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.15. Southeast Asia Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.16. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.17. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.18. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

9.1. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Device
9.1.1.1.1. Therapeutic Devices
9.1.1.1.1.1. Light Box
9.1.1.1.1.2. Desk Lamps
9.1.1.1.1.3. Light Visor
9.1.1.1.1.4. Dawn Simulator
9.1.1.1.2. Diagnostic Devices
9.1.1.1.2.1. Actigraphy Sensors
9.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
9.1.1.1.2.1.2. Wearable Actigraphy Devices
9.1.1.1.2.2. Polysomnography Devices
9.1.1.1.2.2.1. Fixed Polysomnography Devices
9.1.1.1.2.2.2. Portable Polysomnography Devices
9.1.1.2. Drugs
9.1.1.2.1. Benzodiazepines
9.1.1.2.2. Nonbenzodiazepine hypnotics
9.1.1.2.3. Orexin receptor antagonists
9.1.1.2.4. Melatonin receptor agonist
9.1.1.3. Chronotherapy
9.2. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
9.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
9.2.1.3. Non-24-h Sleep-Wake Syndrome
9.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
9.2.1.5. Shift Work Disorder
9.2.1.6. Jet Lag
9.3. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Institutional Sales
9.3.1.1.1. Home Care Settings
9.3.1.1.2. Wellness Centers & Spa
9.3.1.1.3. Sleep Testing Centers
9.3.1.1.4. Specialty Clinics
9.3.1.1.5. Hospitals
9.3.1.2. Retail Sales
9.3.1.2.1. Retail Pharmacies
9.3.1.2.2. Drug Stores
9.3.1.2.3. Online Sales
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Brazil Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.2. Brazil Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.3. Brazil Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.4. Mexico Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.5. Mexico Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.6. Mexico Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.7. Argentina Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.8. Argentina Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.9. Argentina Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.10. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.11. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.1.12. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, 2018 - 2031

10.1. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Device
10.1.1.1.1. Therapeutic Devices
10.1.1.1.1.1. Light Box
10.1.1.1.1.2. Desk Lamps
10.1.1.1.1.3. Light Visor
10.1.1.1.1.4. Dawn Simulator
10.1.1.1.2. Diagnostic Devices
10.1.1.1.2.1. Actigraphy Sensors
10.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
10.1.1.1.2.1.2. Wearable Actigraphy Devices
10.1.1.1.2.2. Polysomnography Devices
10.1.1.1.2.2.1. Fixed Polysomnography Devices
10.1.1.1.2.2.2. Portable Polysomnography Devices
10.1.1.2. Drugs
10.1.1.2.1. Benzodiazepines
10.1.1.2.2. Nonbenzodiazepine hypnotics
10.1.1.2.3. Orexin receptor antagonists
10.1.1.2.4. Melatonin receptor agonist
10.1.1.3. Chronotherapy
10.2. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
10.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
10.2.1.3. Non-24-h Sleep-Wake Syndrome
10.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
10.2.1.5. Shift Work Disorder
10.2.1.6. Jet Lag
10.3. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Institutional Sales
10.3.1.1.1. Home Care Settings
10.3.1.1.2. Wellness Centers & Spa
10.3.1.1.3. Sleep Testing Centers
10.3.1.1.4. Specialty Clinics
10.3.1.1.5. Hospitals
10.3.1.2. Retail Sales
10.3.1.2.1. Retail Pharmacies
10.3.1.2.2. Drug Stores
10.3.1.2.3. Online Sales
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. GCC Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.2. GCC Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.3. GCC Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.4. South Africa Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.5. South Africa Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.6. South Africa Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.7. Egypt Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.8. Egypt Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.9. Egypt Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.10. Nigeria Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.11. Nigeria Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.12. Nigeria Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.13. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.14. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.1.15. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By Treatment Type vs by Disorder Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Natus Medical Incorporated
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Compumedics Ltd.
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Teva Pharmaceutical Industries Ltd.
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. Takeda Pharmaceutical Company
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Koninklijke Philips N.V
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Mylan N.V.
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Fitbit, Inc
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Garmin Ltd
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Lucimed S.A.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. RedMed Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Compass Health Brands (Carex Health)
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Beurer GmbH.
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

Natus Medical Incorporated
Compumedics Ltd.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company
Koninklijke Philips N.V
Mylan N.V.
Fitbit, Inc
Garmin Ltd
Lucimed S.A.
RedMed Inc.
Compass Health Brands (Carex Health)
Beurer GmbH.

Methodology

LOADING...

Growth Factors:

Restraints

Competitive Analysis

Key players in the Circadian Rhythm Sleep Treatment Market including:

Circadian Rhythm Sleep Treatment Market Categorization

Circadian Rhythm Sleep Treatment Market by Disorder

Circadian Rhythm Sleep Treatment Market by Region

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Circadian Rhythm Sleep Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Sleep Service Providers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Circadian Rhythm Sleep Disorders - Market Insights, Competitive Landscape and Market Forecast-2030

The Practice of Sleep Medicine Around The World: Challenges, Knowledge Gaps and Unique Needs

Circadian Rhythm Disorders - Market Insight, Epidemiology and Market Forecast - 2034